Nuo Therapeutics Inc Quick Ratio (NUOT) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Nuo Therapeutics Inc   (NUOT)

Nuo Therapeutics Inc 's Quick Ratio

NUOT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2026, Quick Ratio deteriorated to 0.2 below Nuo Therapeutics Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 163 other companies have achieved higher Quick Ratio than Nuo Therapeutics Inc in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 2500 to 3054.

Explain Quick Ratio?
How much Cash & cash equivalents NUOT´s has?
What are NUOT´s Current Liabilities?




NUOT Quick Ratio (Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
Y / Y Current Liabilities Change 0.73 % 125.81 % 75.98 % 44.7 % 68.25 %
Y / Y Cash & cash equivalent Change 374.04 % 93.49 % -24.72 % -33.12 % -84.8 %
Quick Ratio MRQ 0.2 0.42 0.41 0.32 0.04
NUOT's Total Ranking # 3054 # 2500 # 2193 # 507 # 3642
Seq. Current Liabilities Change -1.23 % 3.96 % 25.78 % -22.01 % 121.42 %
Seq. Cash & cash equivalent Change -51.94 % 6.63 % 62.73 % 468.42 % -80.38 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 164
Healthcare Sector # 795
Overall Market # 3054


Quick Ratio Statistics
High Average Low
7.41 1.16 0.01
(Jun 30 2022)   (Jun 30 2019)




Financial Statements
Nuo Therapeutics Inc 's Current Liabilities $ 1 Millions Visit NUOT's Balance sheet
Nuo Therapeutics Inc 's Cash & cash equivalent $ 0 Millions Visit NUOT's Balance sheet
Source of NUOT's Sales Visit NUOT's Sales by Geography


Cumulative Nuo Therapeutics Inc 's Quick Ratio

NUOT's Quick Ratio for the trailling 12 Months

NUOT Quick Ratio

(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 48.66 % 76.47 % 44.88 % 27.06 % 15.55 %
Y / Y Cash & cash equivalent TTM Growth 9.87 % -20.54 % -52.26 % -43.01 % -32.66 %
Quick Ratio TTM 0.34 0.3 0.28 0.37 0.46
Total Ranking TTM # 3948 # 3011 # 3276 # 722 # 3257
Seq. Current Liabilities TTM Growth 0.19 % 17.69 % 15.19 % 9.46 % 18.93 %
Seq. Cash & cash equivalent TTM Growth 14.5 % 22.66 % -12.62 % -10.47 % -17.19 %


On the trailing twelve months basis NUOT Cash & cash equivalent more than doubled by 374.04 % in Q1 2026 year on year, faster than Current Liabilities, this led to increase in in Nuo Therapeutics Inc 's Quick Ratio to 0.34, Quick Ratio remained below NUOT average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 196 other companies have achieved higher Quick Ratio than Nuo Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2025 from 3011 to 3948.

Explain Quick Ratio?
How much Cash & cash equivalents NUOT´s has?
What are NUOT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 197
Healthcare Sector # 886
Within the Market # 3948


trailing twelve months Quick Ratio Statistics
High Average Low
4.57 1.07 0.08
(Dec 31 2022)   (Sep 30 2021)




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Nuwellis Inc   0.56 $ 2.083  Millions$ 3.730  Millions
Align Technology inc   0.56 $ 1,059.834  Millions$ 1,905.853  Millions
Rosecliff Acquisition Corp I  0.55 $ 11.655  Millions$ 21.273  Millions
Baxter International Inc   0.55 $ 2,017.000  Millions$ 3,693.000  Millions
Avanos Medical Inc   0.54 $ 65.600  Millions$ 120.800  Millions
Edap Tms Sa  0.54 $ 17.291  Millions$ 32.260  Millions
Endra Life Sciences Inc  0.51 $ 0.356  Millions$ 0.701  Millions
Dexcom Inc   0.51 $ 1,118.200  Millions$ 2,203.300  Millions
Sonoma Pharmaceuticals Inc   0.50 $ 2.399  Millions$ 4.832  Millions
Docgo Inc   0.46 $ 35.675  Millions$ 77.217  Millions
Sintx Technologies Inc   0.45 $ 1.889  Millions$ 4.172  Millions
Teleflex Incorporated  0.42 $ 309.411  Millions$ 728.049  Millions
Masimo Corp  0.38 $ 124.600  Millions$ 325.400  Millions
U S Physical Therapy Inc  0.38 $ 28.439  Millions$ 74.519  Millions
Iridex Corp  0.36 $ 4.595  Millions$ 12.828  Millions
Heartsciences Inc   0.34 $ 1.657  Millions$ 4.861  Millions
Envue Medical Inc   0.33 $ 2.235  Millions$ 6.865  Millions
Boston Scientific Corporation  0.32 $ 1,453.000  Millions$ 4,571.000  Millions
Cytosorbents Corporation  0.30 $ 4.813  Millions$ 16.303  Millions
Mountain Crest Acquisition Corp V  0.29 $ 0.097  Millions$ 0.329  Millions
Star Equity Holdings Inc   0.29 $ 8.093  Millions$ 27.757  Millions
Solventum Corporation  0.29 $ 561.000  Millions$ 1,961.000  Millions
Retractable Technologies Inc  0.26 $ 2.766  Millions$ 10.446  Millions
Petvivo Holdings Inc   0.26 $ 0.364  Millions$ 1.377  Millions
Ufp Technologies Inc   0.26 $ 19.976  Millions$ 77.013  Millions
Harvard Apparatus Regenerative Technology Inc   0.25 $ 0.419  Millions$ 1.651  Millions
Milestone Scientific Inc   0.25 $ 1.194  Millions$ 4.858  Millions
Bioventus Inc   0.24 $ 35.846  Millions$ 148.095  Millions
Avita Medical Inc   0.24 $ 16.052  Millions$ 66.671  Millions
Nuo Therapeutics Inc   0.20 $ 0.264  Millions$ 1.290  Millions

Date modified: 2026-09-08T15:11:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.